-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
-
Summary
-
Kestra Medical Technologies, Ltd. quarterly Deferred Tax Assets, Net of Valuation Allowance history and growth rate from Q1 2024 to Q1 2025.
- Kestra Medical Technologies, Ltd. Deferred Tax Assets, Net of Valuation Allowance for the quarter ending April 30, 2025 was $6.88M, a 49.7% increase year-over-year.
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Growth (%)